Clinical Trial Update: Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer [Phase 2]

View source ↗

Summary

A phase 2 clinical trial compared pazopanib plus lapatinib versus lapatinib alone in inflammatory breast cancer; results were posted in July 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2012-07-18